Clinical Trials Logo

Spinal Dysraphism clinical trials

View clinical trials related to Spinal Dysraphism.

Filter by:

NCT ID: NCT00359775 Completed - Asthma Clinical Trials

Coping Skills Training (CST) for Children With Chronic Health Conditions

Start date: July 2006
Phase: Phase 2
Study type: Interventional

Purpose of the study The purpose of this study is to pilot an adapted Coping Skills Training (CST) intervention for feasibility and preliminary efficacy with a sample of children 8 to 12 years of age and their parents. The participants in this study at Children's Hospital of Wisconsin are dealing with one of three chronic health conditions (Rheumatologic Conditions, Epilepsy,Spina Bifida, and Asthma). Research Questions/Study Aims The research questions addressed in the full study are: 1. What is the impact of CST on child depression, QOL, health motivation, attitude toward illness, and self-management efficacy? 2. What is the impact of CST on parent depression, perception of child's quality of life, perception of impact of CHC on family, and family conflict?

NCT ID: NCT00341068 Terminated - Clinical trials for Hereditary Oral Clefts

Genetic Analysis of Neural Tube and Orofacial Cleft Defects in the Irish Population

Start date: January 1, 2000
Phase:
Study type: Observational

In a collaborative effort with the Health Research Board, the national organization for medical research in the Republic of Ireland, individuals with neural tube defects (NTDs) or facial cleft defects and their parents will be studied. With the exception of a few well-described syndromes most cases of NTDs and facial clefts are not inherited in a Mendelian fashion. Nearly all incident cases occur in families with no prior history of the defects. The observed recurrence risk in families with an NTD child is 10-12 fold higher than the general population suggesting that inherited factors modify this risk. Historically, the incidence of NTDs in Ireland was 5-8 fold higher than the USA. The aim of this study is to identify the gene(s) involved in these defects using standard genetic epidemiology approaches, transmission disequilibrium testing and gene mapping strategies. We will initially evaluate genes known to be involved in folate metabolism and pattern formation (development of the body). The major outcomes measured will be aggregate allele frequencies in case groups compared to controls. Biochemical parameters in red cells and plasma will also be measured. Comparisons will be made between the presence of genetics variants, biochemical parameters and clinical phenotype. Characterizing the genes associated with these defects should provide insight into the etiology and metabolic processes that may be involved, furthering prevention and intervention efforts.

NCT ID: NCT00301587 Withdrawn - Neural Tube Defects Clinical Trials

A Study to Evaluate Folate Levels in Women Taking Oral Contraceptives

Start date: n/a
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare red blood cell folate levels in women who are taking oral contraceptives with or without folic acid

NCT ID: NCT00207558 Completed - Clinical trials for Neural Tube Defects - Spina Bifida and Anencephaly

Blood Folate and Homocysteine Levels Following Administration of Folic Acid According to Different Daily Dosing Schedules:a Simulation of Food Fortification

Start date: n/a
Phase: N/A
Study type: Interventional

The aim of this study is to examine whether the same total daily dosage of folic acid, when taken as a single daily dose or as multiple divided doses throughout the day, results in different blood folate and homocysteine levels at the conclusion of the study. Further, a comparison of blood folate and homocysteine levels among women taking daily low-dosage (100mcg) and standard- dosage (400mcg) folic acid with those of women taking daily or weekly high-dosage (4000mcg) folic acid will be conducted.

NCT ID: NCT00207532 Completed - Clinical trials for Spina Bifida and Anencephaly

Dosage Effects of Folic Acid on Blood Folates of Honduran Women

Start date: March 2005
Phase: N/A
Study type: Interventional

CDC staff at the National Center on Birth Defects and Developmental Disabilities have been working closely with a Honduras-based organization, Project Healthy Children (PNS) and the Ministry of Health, on a folic acid supplementation study among female maquila workers. Participants are divided into two groups. One group receives a 1.0 milligram pill daily while the other group receives a 5.0 milligram pill weekly. The aim of this study is to assess serum blood folate levels measured at baseline, midpoint, and endpoint of the study. Hypothesis: Folic acid (5mg)given once weekly is as effective as folic acid (1mg)given daily in raising blood folate levels.

NCT ID: NCT00060606 Completed - Spinal Dysraphism Clinical Trials

Management of Myelomeningocele Study (MOMS)

MOMS
Start date: February 2003
Phase: N/A
Study type: Interventional

Spina bifida (myelomeningocele) is a complex birth defect in which a portion of the spinal cord is not fully developed. The overlying bones and skin are incompletely formed and the underdeveloped area of the spinal cord is exposed on the surface of the back. Spina bifida defects are closed soon after birth to prevent further damage to the spinal cord and nerves. The Management of Myelomeningocele Study (MOMS) is a research study comparing two approaches to the treatment of babies with spina bifida: surgery before birth (prenatal surgery) and the standard closure, surgery after birth (postnatal surgery).

NCT ID: NCT00031122 Active, not recruiting - Spina Bifida Clinical Trials

Study of Genetic Risk Factors for Spina Bifida and Anencephaly

SBRR
Start date: September 2000
Phase: N/A
Study type: Observational

The purpose of this study is to describe the genetic contribution to the neural tube defects spina bifida (SB) and anencephaly (A), which includes identifying patients, defining the roles of certain genes, and studying gene-environment interactions.